Literature DB >> 27521855

Comments on: "Clinical, hematological and genetic data of a cohort of children with hemoglobin SD".

Maria Stella Figueiredo1.   

Abstract

Entities:  

Year:  2016        PMID: 27521855      PMCID: PMC4997905          DOI: 10.1016/j.bjhh.2016.05.012

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


× No keyword cloud information.
Sickle cell disease (SCD) is a group of genetic conditions related to the presence of a sickle hemoglobin (Hb S) mutation (HBB:c.20A>T). People with SCD can be homozygous for Hb S or can have compound heterozygosity for Hb S with other gene mutations.1, 2 Some hematologic features of SCD are listed in Table 1, but rare genotypes can also be found. Since the concentration of Hb S is a pathophysiological factor of disease severity, the presence of lower concentrations of Hb S due to double heterozygosity can determine phenotypic heterogeneity.1, 3 However, other genetic and environmental factors can also have an effect on the disease phenotype.
Table 1

Hematological features of some sickle hemoglobinopathies.

GenotypePCV (%)Retic (%)MCV (fL)Hb F (%)Hb A2 (%)% VariantSeveritya
SCA2589053>90% Hb S++++
Hb SC disease353802350% Hb S, 50% Hb C++
S-β0 thalassemia277827590% Hb S++++
S-β+ thalassemia38270265–30% Hb A++
SCA-α thalassemia3067855>90% Hb S+++
Hb SE disease3537523∼30% Hb E++
Hb SD disease*20861–102–445% Hb S, 45% Hb D+++
Sickle cell trait451851260% Hb A, 40% Hb S

SCA: sickle cell anemia; PCV: packed cell volume; Retic: reticulocyte count; MCV: mean cell volume; Hb: Hemoglobin.

Severity of disease rated from most severe (++++) to absence of clinical events () includes complications related to sickle vaso-occlusion and hemolysis.

Table modified from 1 with * data obtained from 21, 27, 32.

Studies looking for abnormal hemoglobins (Hbs) in the Brazilian population have been performed since the 1950s.5, 6, 7, 8 However, the Brazilian Government Directive MS # 822/01 that regulates newborn screening for hemoglobinopathies, has promoted an increase of data about hemoglobinopathies in different Brazilian regions.9, 10, 11 This associated with the use of isoelectric focusing electrophoresis (IEF) and high-pressure liquid chromatography (HPLC) as diagnostic methods, has enabled the identification of an increasing number of abnormal Hbs as well as compound heterozygous states of Hb S.12, 13, 14 An example is a paper published in this issue of the Revista Brasileira de Hematologia e Hemoterapia that shows data on a cohort of children with hemoglobin SD pattern. Hb D is an abnormal Hb, which migrates to the same position as Hb S in electrophoresis at alkaline pH, and can be separated from Hb S in acid pH.16, 17, 18 Several Hb D have been described in different racial groups, but the majority presented a point mutation in codon 121 of the β-globin gene, which results in the substitution of glutamic acid for glutamine (HBB:c.364G>C). This abnormal Hb is usually called Hb D-Punjab or Hb D-Los Angeles, however it can also be named Hb D-North Carolina, Hb D-Chicago, Hb D-Portugal, Hb D-Cyprus, and Hb D-Oak Ridge.19, 20, 21 The estimated prevalence of Hb D-Punjab is 0.1 to 0.4% in African-Americans. In Brazil, a study of African descendants showed a similar prevalence. Sometime after the discovery of Hb D-Punjab, the coinheritance of Hb D-Punjab and Hb S was identified in Caucasian patients with clinical and hematological manifestations similar to those of sickle cell anemia (SCA), because this mutation facilitates Hb S polymerization.23, 24, 25 Further clinical studies confirmed the severity of the manifestations of this association and the need to treat these individuals as SCA patients by prescribing hydroxyurea when indicated.21, 26, 27, 28, 29 There are other types of Hb D due to different point mutations in the β-globin gene, such as Hb D-Iran (HBB:c.67G>C) and Hb D-Ibadan (HBB:c.263C>A). However, individuals with these mutations have normal hematologic values and do not suffer from vaso-occlusive complications, since their red cells do not sickle under physiologic conditions.18, 30, 31 Hb Korle-Bu (Hb KB) or Hb G-Accra (HBB:c.220G>A) is a frequent mutation in Sub-Saharan Africa.32, 33 This Hb has the same IEF mobility as Hb D-Punjab but can be differentiated by HPLC. Heterozygotes for Hb KB have no hematologic alterations, and individuals with double heterozygosis Hb S-Hb KB have normal red cells on blood smear and a benign clinical course, similar to sickle cell trait as Hb KB does not participate in the gelation of Hb S.33, 34 Interestingly, the Hb KB mutation [beta73(E17)AspAsn] can occur in addition to the Hb S mutation [beta6(A3)Glu6Val] in the same beta globin chain. In this case, this Hb with a double mutation is termed Hb C-Harlem (or Hb C-Georgetown) (HBB:c.20A>T, HBB:c.220G>A), because it migrates to the position of Hb C in cellulose acetate electrophoresis at alkaline pH. Individuals heterozygous for Hb C-Harlem are asymptomatic, but the coinheritance of Hb S and Hb C-Harlem has clinical manifestations similar to SCA.20, 32, 35 Researchers from India and the Middle East are the main authors of the few papers about Hb SD-Punjab; there are less data published about the association Hb S-Hb KB.21, 27, 28, 29, 34, 36, 37, 38, 39, 40, 41 By studying two different groups of patients with Hb SD patterns, specifically Hb SD-Punjab and Hb S-Hb KB, Rezende et al. not only published important clinical data about the coinheritance of two rare Hb but also pointed out the importance of this differential diagnosis.

Conflicts of interest

The author declares no conflicts of interest.
  38 in total

1.  Reliability of isoelectrofocusing for the detection of Hb S, Hb C, and HB D in a pioneering population-based program of newborn screening in Brazil.

Authors:  M C Paixão; M H Cunha Ferraz; J N Januário; M B Viana; J M Lima
Journal:  Hemoglobin       Date:  2001-08       Impact factor: 0.849

2.  Clinical manifestations of inherited abnormal hemoglobins. I. The interaction of hemoglobin-S with hemoglobin-D.

Authors:  P STURGEON; H A ITANO; W R BERGREN
Journal:  Blood       Date:  1955-05       Impact factor: 22.113

3.  Abnormal hemoglobins in a Brazilian Negro population.

Authors:  C V TONDO; F M SALZANO
Journal:  Am J Hum Genet       Date:  1962-12       Impact factor: 11.025

4.  On the prevalence of hemoglobin D in the American Negro.

Authors:  A I CHERNOFF
Journal:  Blood       Date:  1956-10       Impact factor: 22.113

5.  Compound heterozygosity for hemoglobin S [beta6(A3)Glu6Val] and hemoglobin Korle-Bu [beta73(E17)Asp73Asn].

Authors:  Pascale S Akl; Ferdane Kutlar; Niren Patel; Catherine L Salisbury; Peter Lane; Andrew N Young
Journal:  Lab Hematol       Date:  2009

6.  The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab--a single centre experience in eastern India.

Authors:  Siris Patel; Prasanta Purohit; Ranjeet Singh Mashon; Snehadhini Dehury; Satyabrata Meher; Sulia Sahoo; Subhransu Sekhar Dash; Kishalaya Das; Padmalaya Das; Dilip Kumar Patel
Journal:  Pediatr Blood Cancer       Date:  2014-02-24       Impact factor: 3.167

Review 7.  Hereditary haemoglobin disorders in Brazil.

Authors:  M A Zago; F F Costa
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

8.  Facilitation of Hb S polymerization by the substitution of Glu for Gln at beta 121.

Authors:  K Adachi; J Kim; S Ballas; S Surrey; T Asakura
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

9.  Prevalence of thalassemia and hemoglobinopathy in eastern India: A 10-year high-performance liquid chromatography study of 119,336 cases.

Authors:  Santosh Kumar Mondal; Saikat Mandal
Journal:  Asian J Transfus Sci       Date:  2016 Jan-Jun

10.  Clinical, hematological and genetic data of a cohort of children with hemoglobin SD.

Authors:  Paulo do Val Rezende; Kenia da Silva Costa; Jose Carlos Domingues Junior; Paula Barezani Silveira; André Rolim Belisário; Celia Maria Silva; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2016-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.